Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica

L. Boiardi, C. Salvarani, J. M. Timms, T. Silvestri, P. L. Macchioni, F. S. Di Giovine

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective: To investigate whether polymorphisms in the interleukin (IL)-1 locus (human chrom. 2q13) and TNF-α gene are associated with susceptibility to or severity of polymyalgia rheumatica (PMR). Methods: The study included 92 consecutive PMR patients diagnosed over a 5-year period who were prospectively followed-up for at least one year and 79 healthy controls over the age of 50 residing in the same area. All the patients and controls were Caucasians of Italian origin. We tested the allelic distribution of IL-1A (+4845), IL-B (-511), IL-B (+3954), IL-1RN Intron 2 VNTR and TNFA (-308). Frequencies were compared in the patient and control groups. Results: A statistically significant association between PMR patients and the IL1RN*2 allele in the homozygous state was found [OR 8.46 (95% CI 1.05 - 68.31)]. The polymorphisms in the other genes of the IL-1 gene cluster did not reveal any association with PMR when compared with controls. A weak association between PMR patients and the TNF2 allele was also present [OR 2.09 (95% CI 1.0 - 4.17)]. None of the gene variants studied was associated with the disease severity of PMR. Conclusion: Our findings show that IL1RN*2 allele, particularly in the homozygous state, is associated with susceptibility to, but not with the severity of, PMR.

Original languageEnglish
Pages (from-to)675-681
Number of pages7
JournalClinical and Experimental Rheumatology
Volume18
Issue number6
Publication statusPublished - 2000

Fingerprint

Polymyalgia Rheumatica
Interleukin-1
Tumor Necrosis Factor-alpha
Interleukins
Genes
Alleles
Multigene Family
Introns
Control Groups

Keywords

  • Gene polymorphism
  • Interleukin-1 cluster gene polymorphisms
  • Polymyalgia rheumatica
  • Relapse/recurrence
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Boiardi, L., Salvarani, C., Timms, J. M., Silvestri, T., Macchioni, P. L., & Di Giovine, F. S. (2000). Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica. Clinical and Experimental Rheumatology, 18(6), 675-681.

Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica. / Boiardi, L.; Salvarani, C.; Timms, J. M.; Silvestri, T.; Macchioni, P. L.; Di Giovine, F. S.

In: Clinical and Experimental Rheumatology, Vol. 18, No. 6, 2000, p. 675-681.

Research output: Contribution to journalArticle

Boiardi, L, Salvarani, C, Timms, JM, Silvestri, T, Macchioni, PL & Di Giovine, FS 2000, 'Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica', Clinical and Experimental Rheumatology, vol. 18, no. 6, pp. 675-681.
Boiardi, L. ; Salvarani, C. ; Timms, J. M. ; Silvestri, T. ; Macchioni, P. L. ; Di Giovine, F. S. / Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica. In: Clinical and Experimental Rheumatology. 2000 ; Vol. 18, No. 6. pp. 675-681.
@article{9d9d21a9b1f04c4bb7658fb202d5ead7,
title = "Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica",
abstract = "Objective: To investigate whether polymorphisms in the interleukin (IL)-1 locus (human chrom. 2q13) and TNF-α gene are associated with susceptibility to or severity of polymyalgia rheumatica (PMR). Methods: The study included 92 consecutive PMR patients diagnosed over a 5-year period who were prospectively followed-up for at least one year and 79 healthy controls over the age of 50 residing in the same area. All the patients and controls were Caucasians of Italian origin. We tested the allelic distribution of IL-1A (+4845), IL-B (-511), IL-B (+3954), IL-1RN Intron 2 VNTR and TNFA (-308). Frequencies were compared in the patient and control groups. Results: A statistically significant association between PMR patients and the IL1RN*2 allele in the homozygous state was found [OR 8.46 (95{\%} CI 1.05 - 68.31)]. The polymorphisms in the other genes of the IL-1 gene cluster did not reveal any association with PMR when compared with controls. A weak association between PMR patients and the TNF2 allele was also present [OR 2.09 (95{\%} CI 1.0 - 4.17)]. None of the gene variants studied was associated with the disease severity of PMR. Conclusion: Our findings show that IL1RN*2 allele, particularly in the homozygous state, is associated with susceptibility to, but not with the severity of, PMR.",
keywords = "Gene polymorphism, Interleukin-1 cluster gene polymorphisms, Polymyalgia rheumatica, Relapse/recurrence, Tumor necrosis factor-α",
author = "L. Boiardi and C. Salvarani and Timms, {J. M.} and T. Silvestri and Macchioni, {P. L.} and {Di Giovine}, {F. S.}",
year = "2000",
language = "English",
volume = "18",
pages = "675--681",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "6",

}

TY - JOUR

T1 - Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica

AU - Boiardi, L.

AU - Salvarani, C.

AU - Timms, J. M.

AU - Silvestri, T.

AU - Macchioni, P. L.

AU - Di Giovine, F. S.

PY - 2000

Y1 - 2000

N2 - Objective: To investigate whether polymorphisms in the interleukin (IL)-1 locus (human chrom. 2q13) and TNF-α gene are associated with susceptibility to or severity of polymyalgia rheumatica (PMR). Methods: The study included 92 consecutive PMR patients diagnosed over a 5-year period who were prospectively followed-up for at least one year and 79 healthy controls over the age of 50 residing in the same area. All the patients and controls were Caucasians of Italian origin. We tested the allelic distribution of IL-1A (+4845), IL-B (-511), IL-B (+3954), IL-1RN Intron 2 VNTR and TNFA (-308). Frequencies were compared in the patient and control groups. Results: A statistically significant association between PMR patients and the IL1RN*2 allele in the homozygous state was found [OR 8.46 (95% CI 1.05 - 68.31)]. The polymorphisms in the other genes of the IL-1 gene cluster did not reveal any association with PMR when compared with controls. A weak association between PMR patients and the TNF2 allele was also present [OR 2.09 (95% CI 1.0 - 4.17)]. None of the gene variants studied was associated with the disease severity of PMR. Conclusion: Our findings show that IL1RN*2 allele, particularly in the homozygous state, is associated with susceptibility to, but not with the severity of, PMR.

AB - Objective: To investigate whether polymorphisms in the interleukin (IL)-1 locus (human chrom. 2q13) and TNF-α gene are associated with susceptibility to or severity of polymyalgia rheumatica (PMR). Methods: The study included 92 consecutive PMR patients diagnosed over a 5-year period who were prospectively followed-up for at least one year and 79 healthy controls over the age of 50 residing in the same area. All the patients and controls were Caucasians of Italian origin. We tested the allelic distribution of IL-1A (+4845), IL-B (-511), IL-B (+3954), IL-1RN Intron 2 VNTR and TNFA (-308). Frequencies were compared in the patient and control groups. Results: A statistically significant association between PMR patients and the IL1RN*2 allele in the homozygous state was found [OR 8.46 (95% CI 1.05 - 68.31)]. The polymorphisms in the other genes of the IL-1 gene cluster did not reveal any association with PMR when compared with controls. A weak association between PMR patients and the TNF2 allele was also present [OR 2.09 (95% CI 1.0 - 4.17)]. None of the gene variants studied was associated with the disease severity of PMR. Conclusion: Our findings show that IL1RN*2 allele, particularly in the homozygous state, is associated with susceptibility to, but not with the severity of, PMR.

KW - Gene polymorphism

KW - Interleukin-1 cluster gene polymorphisms

KW - Polymyalgia rheumatica

KW - Relapse/recurrence

KW - Tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=0033659406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033659406&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 675

EP - 681

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 6

ER -